APOE and KLF14 genetic variants are sex-specific for low high-density lipoprotein cholesterol identified by a genome-wide association study

Abstract

To demonstrate the loci that relate to high-density lipoprotein cholesterol (HDL-C) levels and genetic sex heterogeneity, we enrolled 41,526 participants aged between 30 and 70 years old from the Taiwan Biobank in a genome-wide association study. We applied the Manhattan plot to display the p-values estimated for the relationships between loci and low HDL-C. A total of 160 variants were significantly associated with low HDL-C. The genotype TT of rs1364422 located in the KLF14 gene has 1.30 (95% CI=1.20 -1.42) times the risk for low-HDL compared to genotype CC in females (log(-p) =8.98). Moreover, the genes APOC1, APOE, PVRL2, and TOMM40 were associated significantly with low-HDL-C in males only. Excluding the variants with high linkage disequilibrium, we revealed the rs429358 located in APOE as the major genetic variant for lowering HDL-C, in which genotype CT has 1.24 (95% CI= 1.16 -1.32) times the risk. In addition, we also examine 12 genes related to HDL-C in both sexes, including LPL, ABCA1, APOA5, BUD13, ZPR1, ALDH1A2, LIPC, CETP, HERPUD1, LIPG, ANGPTL8, and DOCK6. In conclusion, low-HDL-C is a genetic and sex-specific phenotype, and we discovered that the APOE and KLF14 are specific to low-HDL-C for men and women, respectively.

Insulin-AKT1-YBX1 Regulation of ANGPTL8 Promote Lipogenesis in Obstructive Sleep Apnea-Associated Dyslipidemia

“…Comprehensive human genetic inquiries, encompassing whole-genome association analyses, irrefutably substantiate the intimate interconnection between ANGPTL8 and a gamut of metabolic disorders [25][26][27][28]. Moreover, these investigations unveil a multitude of genetic loci within ANGPTL8 intricately intertwined with aberrations in lipid metabolism [25][26][27][28]. Among these loci, rs2278426 (C>T), a non-synonymous single nucleotide polymorphism (SNP) within ANGPTL8, correlates with decreased serum levels of low-density lipoprotein cholesterol (LDL-C) and high-density lipoprotein cholesterol (HDL-C) in African Americans and Hispanics [29].…”

“…In the human context, the regulation of metabolism and the etiology of metabolic diseases frequently bear a discernible genetic signature [21][22][23][24]. Comprehensive human genetic inquiries, encompassing whole-genome association analyses, irrefutably substantiate the intimate interconnection between ANGPTL8 and a gamut of metabolic disorders [25][26][27][28]. Moreover, these investigations unveil a multitude of genetic loci within ANGPTL8 intricately intertwined with aberrations in lipid metabolism [25][26][27][28].…”